Skip to main content

Advertisement

SpringerLink
Log in

In Reply: “On Insulin Kinetics Following High-Dose Insulin Therapy, and When to Stop Therapy”

  • The Poison Pen
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Corcoran JN, Jacoby KJ, Olives TD, Bangh SA, Cole JB. Persistent hyperinsulinemia following high-dose insulin therapy: a case report. J Med Toxicol. 2020;16:465–9.

    Article  Google Scholar 

  2. Rabkin R, Ryan MP, Duckworth WC. The renal metabolism of insulin. Diabetologia. 1984;27:351–7.

    Article  CAS  Google Scholar 

  3. Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, DeFronzo RA. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol-Endocrinol Metab. 1983;244:E517–27.

    Article  CAS  Google Scholar 

  4. Rabkin R, Simon NM, Steiner S, Colwell JA (2010) Effect of renal disease on renal uptake and excretion of insulin in man. N Engl J Med 1970; 282:182–187.

  5. Katz AI, Rubenstein AH. Metabolism of proinsulin, insulin, and C-peptide in the rat. J Clin Invest. 1973;52:1113–21.

    Article  CAS  Google Scholar 

  6. Waldhäusl WK, Bratusch-Marrain PR, Vierhapper H, Nowotny P. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man. Metabolism. 1983;32:478–86.

    Article  Google Scholar 

  7. Tomasi T, Sledz D, Wales JK, Recant L. Insulin half-life in normal and diabetic subjects. Exp Biol Med. 1967;126:315–7.

    Article  CAS  Google Scholar 

  8. Cole JB, Arens AM, Laes JR, Klein LR, Bangh SA, Olives TD. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018;36:1817–24.

    Article  Google Scholar 

  9. Fasching P, Roden M, Stühlinger HG, Kurzemann S, Zeiner A, Waldhäusl W, et al. Estimated glucose requirement following massive insulin overdose in a patient with type 1 diabetes. Diabet Med. 1994;11:323–5.

    Article  CAS  Google Scholar 

  10. Mégarbane B, Deye N, Bloch V, Sonneville R, Collet C, Launay J-M, et al. Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles. Crit Care. 2007;11:R115.

    Article  Google Scholar 

  11. Shibutani Y, Ogawa C. Suicidal insulin overdose in a type 1 diabetic patient: relation of serum insulin concentrations to the duration of hypoglycemia. J Diabetes Complications. 2000;14:60–2.

    Article  CAS  Google Scholar 

  12. Holger JS, Stellpflug SJ, Cole JB, Harris CR, Engebretsen KM. High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock. Clin Toxicol. 2011;49:653–8.

    Article  CAS  Google Scholar 

Download references

Funding

There are no sources of funding.

Author information

Authors and Affiliations

  1. Medical College of Wisconsin, Hub for Collaborative Medicine, 8701 Watertown Plank Road, 53226, Milwaukee, WI, USA

    Justin N. Corcoran

  2. Emergency Care Consultants, Minneapolis, MN, USA

    Katherine J. Jacoby

  3. Minnesota Poison Control System, Minneapolis, MN, USA

    Travis D. Olives, Stacey A. Bangh & Jon B. Cole

Authors
  1. Justin N. Corcoran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katherine J. Jacoby
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Travis D. Olives
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stacey A. Bangh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jon B. Cole
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Justin N. Corcoran.

Ethics declarations

Conflict of Interest

There are no conflicts of interest.

Additional information

Supervising Editor: Lewis S. Nelson, MD

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Corcoran, J.N., Jacoby, K.J., Olives, T.D. et al. In Reply: “On Insulin Kinetics Following High-Dose Insulin Therapy, and When to Stop Therapy”. J. Med. Toxicol. 17, 235–236 (2021). https://doi.org/10.1007/s13181-021-00829-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-021-00829-4

Search

Navigation